{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:59:49Z","timestamp":1783691989123,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2024AFB471"],"award-info":[{"award-number":["2024AFB471"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.urolonc.2025.08.020","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T23:25:20Z","timestamp":1758065120000},"page":"706.e11-706.e25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Senescence-associated miRNAs predict survival and modulate the tumor immune microenvironment via SPOCK1 targeting in clear cell renal cell carcinoma"],"prefix":"10.1016","volume":"43","author":[{"given":"Zheng","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyue","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.urolonc.2025.08.020_bib0001","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41419-021-03955-7","article-title":"LncRNA RCAT1 promotes tumor progression and metastasis via miR-214-5p\/E2F2 axis in renal cell carcinoma","volume":"12","author":"Guo","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.urolonc.2025.08.020_bib0002","article-title":"A mitochondrial dysfunction and oxidative stress pathway-based prognostic signature for clear cell renal cell carcinoma","volume":"2021","author":"Wu","year":"2021","journal-title":"Oxid Med Cell Longev"},{"issue":"16","key":"10.1016\/j.urolonc.2025.08.020_bib0003","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1002\/cam4.4679","article-title":"Combining immune checkpoint inhibition plus tyrosine kinase inhibition as first and subsequent treatments for metastatic renal cell carcinoma","volume":"11","author":"Yang","year":"2022","journal-title":"Cancer Med"},{"issue":"9","key":"10.1016\/j.urolonc.2025.08.020_bib0004","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1200\/JCO.2017.74.2627","article-title":"Phase I dose-escalation trial of PT2385, a first-in-class hypoxia-inducible factor-2\u03b1 antagonist in patients with previously treated advanced clear cell renal cell carcinoma","volume":"36","author":"Courtney","year":"2018","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.urolonc.2025.08.020_bib0005","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1158\/2159-8290.CD-19-0499","article-title":"Tumor microenvironment dynamics in clear-cell renal cell carcinoma","volume":"9","author":"Vuong","year":"2019","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.urolonc.2025.08.020_bib0006","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.cell.2017.04.016","article-title":"An immune atlas of clear cell renal cell carcinoma","volume":"169","author":"Chevrier","year":"2017","journal-title":"Cell."},{"issue":"2","key":"10.1016\/j.urolonc.2025.08.020_bib0007","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1152\/physrev.00020.2018","article-title":"Cellular senescence: aging, cancer, and injury","volume":"99","author":"Calcinotto","year":"2019","journal-title":"Physiol Rev"},{"issue":"8","key":"10.1016\/j.urolonc.2025.08.020_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082134","article-title":"Senescence and cancer: a review of clinical implications of senescence and senotherapies","volume":"12","author":"Wyld","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.urolonc.2025.08.020_bib0009","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O'Brien","year":"2018","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"1","key":"10.1016\/j.urolonc.2025.08.020_bib0010","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10565-022-09761-x","article-title":"The role of microRNAs in neurodegenerative diseases: a review","volume":"39","author":"Li","year":"2023","journal-title":"Cell Biol Toxicol"},{"issue":"12","key":"10.1016\/j.urolonc.2025.08.020_bib0011","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.urolonc.2025.08.020_bib0012","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.otohns.2010.05.007","article-title":"A practical guide to understanding Kaplan-Meier curves","volume":"143","author":"Rich","year":"2010","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.urolonc.2025.08.020_bib0013","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling tumor infiltrating immune cells with CIBERSORT","volume":"1711","author":"Chen","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.urolonc.2025.08.020_bib0014","doi-asserted-by":"crossref","DOI":"10.1177\/11769343211058463","article-title":"Screening of important factors in the early sepsis stage based on the evaluation of ssGSEA algorithm and ceRNA regulatory network","volume":"17","author":"Huang","year":"2021","journal-title":"Evol Bioinform Online"},{"key":"10.1016\/j.urolonc.2025.08.020_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1373497","article-title":"Biological effects of intraoperative radiation therapy: histopathological changes and immunomodulation in breast cancer patients","volume":"15","author":"Orozco","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.urolonc.2025.08.020_bib0016","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nature Commun"},{"issue":"11","key":"10.1016\/j.urolonc.2025.08.020_bib0017","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/2159-8290.CD-17-0401","article-title":"Recurrent tumor cell-intrinsic and -extrinsic alterations during MAPKi-induced melanoma regression and early adaptation","volume":"7","author":"Song","year":"2017","journal-title":"Cancer Discov"},{"issue":"12","key":"10.1016\/j.urolonc.2025.08.020_bib0018","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"1","key":"10.1016\/j.urolonc.2025.08.020_bib0019","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"10.1016\/j.urolonc.2025.08.020_bib0020","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/pro.3715","article-title":"Toward understanding the origin and evolution of cellular organisms","volume":"28","author":"Kanehisa","year":"2019","journal-title":"Protein Sci"},{"issue":"D1","key":"10.1016\/j.urolonc.2025.08.020_bib0021","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/nar\/gkac963","article-title":"KEGG for taxonomy-based analysis of pathways and genomes","volume":"51","author":"Kanehisa","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"36","key":"10.1016\/j.urolonc.2025.08.020_bib0022","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1200\/JCO.18.01198","article-title":"Progress in kidney cancer outcomes through collaboration, innovation, and discovery","volume":"36","author":"McDermott","year":"2018","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.urolonc.2025.08.020_bib0023","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1016\/j.apsb.2022.11.001","article-title":"Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy","volume":"12","author":"Xu","year":"2022","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"10.1016\/j.urolonc.2025.08.020_bib0024","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/cam4.2769","article-title":"Concordance of PD-1 and PD-L1 (B7-H1) in paired primary and metastatic clear cell renal cell carcinoma","volume":"9","author":"Eckel-Passow","year":"2020","journal-title":"Cancer Med"},{"issue":"7","key":"10.1016\/j.urolonc.2025.08.020_bib0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1503\/cmaj.230356","article-title":"Advances in the management of renal cell carcinoma","volume":"196","author":"Cardenas","year":"2024","journal-title":"Cmaj"},{"issue":"5","key":"10.1016\/j.urolonc.2025.08.020_bib0026","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/cells13050441","article-title":"The role of oxidative stress in tumorigenesis and progression","volume":"13","author":"Li","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.urolonc.2025.08.020_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.645593","article-title":"Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory phenotype","volume":"9","author":"Kumari","year":"2021","journal-title":"Front Cell Dev Biol."},{"issue":"6","key":"10.1016\/j.urolonc.2025.08.020_bib0028","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41568-022-00450-9","article-title":"Exploiting senescence for the treatment of cancer","volume":"22","author":"Wang","year":"2022","journal-title":"Nature Rev Cancer"},{"issue":"11","key":"10.1016\/j.urolonc.2025.08.020_bib0029","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/s43018-022-00462-2","article-title":"cFLIP suppression and DR5 activation sensitize senescent cancer cells to senolysis","volume":"3","author":"Wang","year":"2022","journal-title":"Nat Cancer"},{"key":"10.1016\/j.urolonc.2025.08.020_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41568-022-00503-z","article-title":"Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation","volume":"22","author":"Kandalaft","year":"2022","journal-title":"Nature Rev Cancer"},{"issue":"1","key":"10.1016\/j.urolonc.2025.08.020_bib0031","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13045-022-01363-8","article-title":"Combination of oral STING agonist MSA-2 and anti-TGF-\u03b2\/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors","volume":"15","author":"Yi","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"7","key":"10.1016\/j.urolonc.2025.08.020_bib0032","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.it.2022.04.010","article-title":"Turning cold tumors hot: from molecular mechanisms to clinical applications","volume":"43","author":"Zhang","year":"2022","journal-title":"Trends Immunol"},{"issue":"17","key":"10.1016\/j.urolonc.2025.08.020_bib0033","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14174298","article-title":"Intratumoral niches of B cells and follicular helper T cells, and the absence of regulatory T cells, associate with longer survival in early-stage oral tongue cancer patients","volume":"14","author":"Phanthunane","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.urolonc.2025.08.020_bib0034","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004022","article-title":"CD4(+) T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1\/PD-L1 immunotherapy","volume":"10","author":"Xiao","year":"2022","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.urolonc.2025.08.020_bib0035","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1186\/s12967-023-04616-3","article-title":"SPOCK1, as a potential prognostic and therapeutic biomarker for lung adenocarcinoma, is associated with epithelial-mesenchymal transition and immune evasion","volume":"21","author":"Liu","year":"2023","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.urolonc.2025.08.020_bib0036","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12957-023-03189-1","article-title":"Screening and identifying of biomarkers in early colorectal cancer and adenoma based on genome-wide methylation profiles","volume":"21","author":"He","year":"2023","journal-title":"World J Surg Oncol"},{"issue":"11","key":"10.1016\/j.urolonc.2025.08.020_bib0037","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1002\/1878-0261.13529","article-title":"A protein complex of LCN2, LOXL2 and MMP9 facilitates tumour metastasis in oesophageal cancer","volume":"17","author":"Xia","year":"2023","journal-title":"Mol Oncol"},{"issue":"8","key":"10.1016\/j.urolonc.2025.08.020_bib0038","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25084214","article-title":"Machine learning gene signature to metastatic ccRCC based on ceRNA network","volume":"25","author":"Farias","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.urolonc.2025.08.020_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1163977","article-title":"Comprehensive analysis to construct a novel immune-related prognostic panel in aging-related gastric cancer based on the lncRNA\u2012miRNA-mRNA ceRNA network","volume":"10","author":"Deng","year":"2023","journal-title":"Front Mol Biosci"},{"issue":"7","key":"10.1016\/j.urolonc.2025.08.020_bib0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073683","article-title":"Analysis of microRNAs in exosomes of breast cancer patients in search of molecular prognostic factors in brain metastases","volume":"23","author":"Curtaz","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925003400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925003400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:17:14Z","timestamp":1772882234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925003400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1078143925003400"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.08.020","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Senescence-associated miRNAs predict survival and modulate the tumor immune microenvironment via SPOCK1 targeting in clear cell renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}